Search PubMed⌕ Search

Biomedical subjects

R Levenson

Publications and source records attributed to R Levenson.

At least 91 records · Page 5Linked to original sources

Growth factor- and dexamethasone-induced proteins in Swiss 3T3 cells. Relationship to DNA synthesis.

Dexamethasone synergistically enhances the stimulation of DNA synthesis in quiescent Swiss 3T3 cells by cartilage-derived growth factor (CDGF) while having no consistent effect when added with platelet-derived growth factor (PDGF) or serum. We examined the hypothesis that this difference might be attributed to selective synthesis of individual proteins early in the G1 phase of the cell cycle. Swiss 3T3 cells were treated with CDGF, PDGF, and fetal bovine serum for 3 h, with or without dexamethasone, and [35S]methionine-labeled proteins were separated by two-dimensional electrophoresis on giant gels. Over 3300 proteins could be distinguished; 34 of these were consistently induced more than 3-fold by all three factors, while an additional 30 inductions were variably present. Dexamethasone by itself induced 8 other proteins, and at least 9 growth factor inductions were synergistically enhanced by addition of the hormone. To identify proteins intimately associated with growth control, we looked for inductions that reflected the dexamethasone synergy with CDGF on DNA synthesis and lack of such an effect with PDGF. The induction of only one group of proteins, the Band 1 isoforms (44-46 kDa, pI 6.1-5.9) displayed such selective synergy. The majority of the other growth factor inductions were inhibited by dexamethasone, even in the context of maximal DNA synthesis, implying that their increased synthesis is not required for growth. When 3T3 cells were treated with increasing doses of CDGF with and without dexamethasone, autoradiographic densities of induced proteins varied in a dose-responsive fashion. However, only levels of the Band 1 proteins bore a constant linear relationship to DNA synthesis, suggesting that they play an important role in early control of the cell cycle.

Animals↗

Expression of an ouabain resistance gene in transfected cells. Ouabain treatment induces a K+-transport system.

We have investigated the expression of a cloned mouse gene which confers ouabain resistance to African green monkey kidney (CV1) cells. CV1 cells carrying the transfected ouabain resistance (ouaR) gene express an ouabain-inducible K+-transport system. This K+-transport system is not a normal (Na,K)-ATPase since plasma membranes prepared from the transfected cells have significantly reduced Na+-stimulated ATPase activity. RNA sequences homologous to the transfected gene are observed in abundance only following exposure of transfectants to ouabain. The small size of the message induced (1.2 kilobases) also argues that the gene does not code for the alpha-subunit of the (Na,K)-ATPase. Ouabain-treated transfected cells maintain an internal [K+] of 113 mM; a level close to the 139 mM of control cells. However, ouabain-treated transfectants exhibit an internal [Na+] of 61 mM, which is 3-6 times the level in untreated cells (11-21 mM). These results suggest: ouabain resistance can be conferred by a gene which codes for an ouabain-inducible K+-transport system; induction of this transport system by ouabain is due to increased levels of mRNA coded for by the ouabain resistance gene; and the ouabain resistance gene does not encode for the alpha-subunit of the (Na,K)-ATPase.

Animals↗

Molecular cloning of rat brain Na,K-ATPase alpha-subunit cDNA.

We have isolated a cDNA clone for the rat brain Na,K-ATPase alpha subunit. A lambda gt11 cDNA expression library constructed from mRNA of 1- and 2-week-old rat brains was screened with an antibody reactive with rat brain Na,K-ATPase. A positive phage clone, lambda rb5, containing a 1200-base-pair cDNA insert expressed a beta-galactosidase-cDNA fusion protein that was reactive by immunoblotting with the Na,K-ATPase antibody. This fusion protein was also reactive in ELISA with a monoclonal antibody directed against the alpha subunit of the Na,K-ATPase. A 27S mRNA species exhibiting sequence hybridization to the cDNA insert of lambda rb5 was identified in rat brain, kidney, and liver, as well as in dog kidney. This 27S mRNA exhibited a tissue-specific pattern of abundance consistent with the relative abundance of Na,K-ATPase polypeptides in vivo: kidney greater than brain greater than liver. In a ouabain-resistant HeLa cell line, C+, which contains minute chromosomes and at least a 10-fold greater number of sodium pumps than parental HeLa cells, DNA sequences complementary to lambda rb5 cDNA were amplified approximately 40-fold. Analysis of the lambda rb5 cDNA sequence demonstrated a perfect nucleotide sequence match between a portion of the cDNA and the amino acid sequence of the Na,K-ATPase alpha-subunit fluorescein isothiocyanate binding site. Taken together, the data presented here demonstrate that the lambda rb5 cDNA clone is a portion of the gene coding for the rat brain Na,K-ATPase alpha subunit. The ATPase gene appears to be present in one or very few copies in the rat and human genomes and to be transcriptionally regulated in different rat tissues. In a ouabain-resistant human cell line, on the other hand, ouabain resistance appears to involve an increase in the number of gene copies coding for the Na,K-ATPase.

Animals↗

Molecular cloning of the mouse ouabain-resistance gene.

DNA prepared from ouabain-resistant mouse cells was able to transform ouabain-sensitive CV-1 cells to ouabain resistance after DNA-mediated gene transfer. The murine DNA fragment responsible for ouabain resistance was detected on the background of CV-1 DNA by virtue of a repetitive DNA sequence element that reacts positively with a mouse repeat DNA clone. CV-1 DNA is nonreactive with this probe. Southern analysis of several independently derived ouabain-resistant transformants indicates that the mouse ouaR gene is located on a 6.5-kilobase EcoRI restriction fragment. The 6.5-kilobase DNA fragment was initially isolated from a lambda phage library made from a ouabain-resistant secondary transformant and subsequently was subcloned in the plasmid vector pAT153. This plasmid was able to transform wild-type CV-1 cells to ouabain resistance at a frequency of about 10 cells per ng of DNA.

Animals↗

Ionic regulation of MEL cell commitment.

A key event in the initiation of the dimethyl sulfoxide (DMSO)-induced program of murine erythroleukemia (MEL) cell differentiation is a rise in the level of cytoplasmic calcium ions. Our interest in the present study is whether other inducers of the terminal erythroid differentiation program also act via a calcium-dependent pathway. Inhibition of calcium transport has been found to prevent the induction of MEL cell commitment by DMSO, butyric acid (BA), or hypoxanthine (HX). Enhancement of the calcium flux rate with A23187 or elevation of cytoplasmic calcium levels with FCCP stimulates the kinetics of commitment in response to all three inducers. These results suggest that of the inducers we have tested (DMSO, BA, and HX), all three act to initiate commitment via a common mechanism which involves modulation of cytoplasmic calcium levels.

Animals↗

Evidence that a Na+/Ca2+ antiport system regulates murine erythroleukemia cell differentiation.

The Na+ and Ca2+ transport properties of cultured murine erythroleukemia (MEL) cells have been investigated. We have previously shown that amiloride prevents dimethyl sulfoxide-induced MEL cell differentiation via inhibition of an essential Ca2+ influx (levenson, R., Housman, D., and Cantley, L. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 5948-5952). Here we show that external Na+ inhibits Ca2+ influx and stimulates Ca2+ efflux from uninduced MEL cells. Increasing the internal Na+ concentration by a brief incubation of cells with ouabain stimulates the rate of 45Ca2+ influx. Amiloride (40 microM) completely blocks the external Na+-stimulated 45Ca2+ efflux and external Na+-inhibitable 45Ca2+ influx. The same concentration of amiloride had no significant effect on net Na+ uptake. These results suggest that a significant fraction of Ca2+ flux across the MEL cell plasma membrane occurs via a Na+/Ca2+ antiport system and that amiloride prevents differentiation by blocking Ca2+ influx through this system. The importance of a Na+/Ca2+ antiport system for MEL cell differentiation is supported by the following observation: increasing the cellular Na+ level by a brief treatment with ouabain plus monensin accelerates MEL cell commitment as effectively as adding the Ca2+ ionophore A23187. We suggest that dimethyl sulfoxide induces MEL cell differentiation by inhibiting the Na+ pump and consequently allowing Ca2+ influx through the Na+/Ca2+ antiport.

Amiloride↗

Role of mitochondrial membrane potential in the regulation of murine erythroleukemia cell differentiation.

The level of cytoplasmic calcium ions appears to be important in the control of murine erythroleukemia (MEL) cell differentiation. Our interest in this study focuses on the relationship between the regulation of calcium concentration and differentiation. We used the fluorescent membrane probe DiOC6 to examine the relationship between MEL cell mitochondria and changes in cytoplasmic calcium levels occurring at the initiation of commitment. Fluorescence microscopy reveals the selective association of DiOC6 with MEL cell mitochondria, where an enhanced fluorescence is observed. Treatment of cells with dimethylsulfoxide (DMSO) or other inducers causes a decrease in mitochondria-associated fluorescence levels that occurs with the initiation of commitment. A decrease in DiOC6 fluorescence is caused by agents that reduce mitochondrial membrane potential, but is only slightly affected by agents that alter plasma membrane potential. Amiloride and EGTA, agents that prevent commitment and inhibit calcium uptake, also prevent the decrease in DiOC6 uptake caused by DMSO. The effect of DMSO on MEL cell mitochondria is mimicked by FCCP, a proton ionophore that dissipates mitochondrial membrane potential. FCCP also caused MEL cell mitochondria to release calcium into the cytoplasm. When MEL cells are treated with DMSO plus FCCP, commitment is initiated without the lag period observed when cells are treated with DMSO alone. These results are consistent with the hypothesis that mitochondrial transmembrane potential is important in the regulation of cytoplasmic calcium levels at the time of commitment of MEL cells to terminal differentiation.

Amiloride↗

Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation.

An alteration in the rate of calcium transport appears to be the rate-limiting event for the commitment of murine erythroleukemia (MEL) cells to initiate a program of terminal erythroid differentiation. The dimethyl sulfoxide (DMSO)-induced commitment of MEL cells to erythroid differentiation can be inhibited by treatment of cells with the calcium-chelating agent EGTA. Upon removal of EGTA, cells initiate commitment without the 12-h lag normally observed after treatment with DMSO alone. Treatment of cells with DMSO in the presence of calcium ionophore A23187 causes cells to initiate commitment from time zero with no lag. These results suggest that the lag is the time required for DMSO to alter the calcium transport properties of the cell.

Animals↗

Effect of glucagon on zinc excretion in anesthetized dogs.

The present studies were performed on anesthetized dogs to determine whether urinary zinc excretion is altered when plasma glucagon concentration is elevated acutely. Glucagon infusion (5 ng.kg-1.min-1) adequate to double base-line plasma glucagon significantly increased zinc excretion in a reversible manner; plasma zinc concentration was unchanged. A larger dose of glucagon (50 ng.kg-1.min-1) produced no significantly greater effect. Clearance experiments using 65Zn to measure ultrafilterable zinc concentration revealed no change in ultrafilterable zinc during glucagon infusion. In a third series of experiments, acetylcholine (25 micrograms/min) was infused into one renal artery while zinc excretion and renal function of the two kidneys were compared. Acetylcholine did not significantly alter zinc excretion despite large changes in sodium and water excretion. The changes in zinc excretion observed in all experiments correlated well with glomerular filtration rate changes, but additional contributions of changes in tubular handling of zinc cannot be ruled out.

Acetylcholine↗

Amiloride inhibits murine erythroleukemia cell differentiation: evidence for a Ca2+ requirement for commitment.

The effect of amiloride (an inhibitor of passive Na+ transport in many tissues) on the differentiation of murine erythroleukemia cells was investigated. Amiloride completely blocked the dimethyl sulfoxide (Me2SO)-induced erythroid differentiation of cells at a concentration (10 microgram/ml) that did not affect cell proliferation. Amiloride also prevented the decrease in cell volume normally observed afte a 20-hr exposure to Me2SO. The ratio of total cell Na+ to total cell water was essentially the same for control cells, Me2SO-treated cells, and cells treated with Me2SO plus amiloride. However, cells treated for 24 hr with Me2SO had a rate of Ca2+ uptake that was twice that of untreated cells and a similarly higher Ca2+ content. Addition of amiloride plus Me2SO prevented both the increase in Ca2+ uptake rate and the increase in Ca2+ content. Cells grown in the presence of Me2SO plus amiloride initiated differentiation immediately after removal of amiloride or addition of the Ca2+ ionophore A23187 (1 microgram/ml). Addition of sufficient ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid to reduce free extracellular Ca2+ to submicromolar levels prevented Me2SO-induced differentiation while only slightly affecting cell proliferation. These results suggest that an increase in in the Ca2+ level is an essential step in Me2SO induction, that amiloride either directly or indirectly inhibits this process, and that Me2SO has an early effect on cells that is necessary for differentiation and is not mimicked by A23187.

Amiloride↗

Synchronization of MEL cell commitment with cordycepin.

The response of differentiating MEL cells to the nucleotide analogue cordycepin reveals a previously unrecognized aspect of the molecular events which cause commitment of these cells to terminal erythroid differentiation. Cordycepin rapidly inhibits commitment of DMSO-treated MEL cells in a dose range which does not cause cytotoxicity. Reversal of cordycepin treatment in the presence of inducer leads to a rapid and synchronous commitment of a significant proportion of cells in the culture. These results suggest that MEL cells can be blocked just prior to the point of commitment by cordycepin treatment.

Animals↗

Memory of MEL cells to a previous exposure to inducer.

The mechanism of commitment of murine erythroleukemia (MEL) cells to terminal differentiation has been examined. Before a significant proportion of cells becomes committed, a lag period of at least 9 hr of exposure to inducer is observed. Cells withdrawn from inducer can reinitiate commitment without a lag when reexposed. The proportion of committed cells in a culture discontinuously exposed to inducer is identical to that in a continuously exposed culture even if withdrawal from inducer lasts for 18 hr. The ability to tolerate an interruption in the exposure has been termed "memory." The memory of a previous exposure to inducer is complete up to 18 hr. It is partially erased after 36 hr and completely erased after 72 hr. The length of time the memory persists is not affected by the length of the initial exposure to inducer. These results suggest that a cellular component necessary for the commitment event accumulates in response to inducer and that this component has a decay time on the order of 10 hr.

Animals↗

Developmental program of murine erythroleukemia cells. Effect of the inhibition of protein synthesis.

The relationship between protein synthesis and commitment to terminal erythroid differentiation by dimethylsulfoxide-treated murine erythroleukemia (MEL) cells has been studied. Treatment with cycloheximide blocks the commitment of MEL cells. The effects of cycloheximide are completely reversible, however. Treatment of MEL cells before commitment delays commitment for a period of time equal to the length of inhibitor treatment. Puromycin exerts a similar effect on the commitment of MEL cells. These results indicate that there is a continuous requirement for protein synthesis before the commitment event.

Animals↗